rhTNK-tPA
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke (NCT07519889) | CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. | 2026-04-10 |
Track rhTNK-tPA automatically
Every clearance here is in the API, with alerts when new ones post.